Evidence map›Paper›PMID 39494554›Full record

ArticleMicrobial genomics2024

Longitudinal genomic surveillance of a UK intensive care unit shows a lack of patient colonisation by multi-drug-resistant Gram-negative bacterial pathogens.

Ann E Snaith, Robert A Moran, Rebecca J Hall, Anna Casey, Liz Ratcliffe, Willem van Schaik, Tony Whitehouse, Alan McNally

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ann E SnaithInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Robert A MoranInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Rebecca J HallInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Anna CaseyQueen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.
Liz RatcliffeQueen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.
Willem van SchaikInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Tony WhitehouseQueen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.
Alan McNallyInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Vulnerable patients in an intensive care unit (ICU) setting are at high risk of infection from bacteria including gut-colonising

Indexed as

COVID-19Drug Resistance, Multiple, BacterialEscherichia coliIntensive Care UnitsAnti-Bacterial AgentsCross InfectionGenome, BacterialGenomicsGram-Negative BacteriaHumansSARS-CoV-2United KingdomWhole Genome SequencingAnti-Bacterial AgentsAMRE. coliICU

Identifiers

PMID39494554
PMCPMC11533117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.